esmo.org Report : Visit Site

Technical data of the esmo.org

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host esmo.org. Currently, hosted in United States and its service provider is Perimeter Technology Inc. .

the related websites

alte.org efdgroup.eu riotintoalcan.com coe.int nutraingredients.com toshibamea.com anthropologie.eu here.com voxeu.org plantronics.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

sign in menu welcome to the european society for medical oncology , the leading european professional organisation for medical oncology. search topic breast cancer lung cancer and mesothelioma gastrointestinal cancer -- sign in search about us esmo magazine who we are how we work esmo oncology journals leading perspectives connect with esmo esmo 40th anniversary esmo faculty connect with esmo discover esmo's new social media dashboard where you will find all your favourite posts and tweets in one place! esmo 40th anniversary #esmo40 celebrate with us: watch our anniversary videos, take a virtual stroll through our timeline of 'esmo firsts' or share your wishes for the future with us… membership join esmo member benefits esmo booth esmo in your country esmo calendar membership committee join esmo there are many good reasons to become an esmo member. find out why you should join europe's leading medical oncology society member benefits see the full list of benefits that esmo members enjoy including access to oncologypro, subscription to annals of oncology and reduced meeting registration fees esmo booth the esmo membership booth will be at several oncology meetings in 2018. see where we'll be next! esmo in your country our network of national representatives act as ambassadors of esmo’s mission in their respective country esmo calendar all the important esmo dates and deadlines in a single place - don't miss out, update your diaries now! guidelines guidelines news breast cancer cancers of unknown primary site endocrine and neuroendocrine c... gastrointestinal cancers genitourinary cancers gynaecological cancers haematological malignancies head and neck cancers hereditary syndromes lung and chest tumours melanoma neuro-oncology sarcoma and gist supportive and palliative care esmo-mcbs pocket guidelines & mobile app esmo guidelines methodology guidelines news keep up to date with news about esmo guidelines, including the latest cpg publications, updated recommendations, algorithms, pocket guidelines and mcbs grading breast cancer 4th eso–esmo international consensus guidelines for advanced breast cancer (abc4) • prevention and screening in brca mutation carriers and other breast/ovarian hereditary cancer syndromes • primary breast cancer cancers of unknown primary site cancers of unknown primary site endocrine and neuroendocrine cancers neuroendocrine bronchial and thymic tumours • neuroendocrine gastroenteropancreatic tumours • adrenal cancer • thyroid cancer gastrointestinal cancers rectal cancer • biliary cancer • gastric cancer • oesophageal cancer • cancer of the pancreas • metastatic colorectal cancer • anal cancer • early colon cancer • familial risk colorectal cancer • hepatocellular carcinoma genitourinary cancers testicular germ cell cancer • cancer of the prostate • bladder cancer • renal cell carcinoma • penile carcinoma • testicular seminoma and non-seminoma gynaecological cancers cervical cancer • endometrial cancer • gestational trophoblastic disease • newly diagnosed and relapsed epithelial ovarian carcinoma • non-epithelial ovarian cancer haematological malignancies waldenstrom's macroglobulinaemia • chronic myeloid leukaemia • newly diagnosed and relapsed mantle cell lymphoma • multiple myeloma • newly diagnosed and relapsed follicular lymphoma • extranodal diffuse large b-cell lymphoma and primary mediastinal b-cell lymphoma • acute lymphoblastic leukaemia • peripheral t-cell lymphomas • diffuse large b cell lymphoma • chronic lymphocytic leukaemia • hairy cell leukaemia • philadelphia chromosome-negative chronic myeloproliferative neoplasms • myelodysplastic syndromes • hodgkin lymphoma • primary cutaneous lymphomas • acute myeloblastic leukaemia in adult patients • gastric marginal zone lymphoma of malt type head and neck cancers nasopharyngeal cancer • squamous-cell carcinoma of the head and neck hereditary syndromes prevention and screening in brca mutation carriers and other breast/ovarian hereditary cancer syndromes lung and chest tumours early and locally advanced non-small-cell lung cancer • metastatic non-small-cell lung cancer • thymic epithelial tumours • malignant pleural mesothelioma • small-cell lung cancer melanoma cutaneous melanoma neuro-oncology eano and esmo guidelines on leptomeningeal metastasis from solid tumours • high-grade malignant glioma sarcoma and gist soft tissue and visceral sarcomas • gastrointestinal stromal tumours • bone sarcomas supportive and palliative care constipation in advanced cancer • delirium in adult cancer • diarrhoea in adult cancer patients patients • management of anaemia and iron deficiency in patients with cancer • management of infusion reactions to systemic anticancer therapy • management of toxicities from immunotherapy • management of febrile neutropaenia • mascc and esmo consensus guidelines for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting • treatment of dyspnoea in advanced cancer patients • central venous access in oncology • management of oral and gastrointestinal mucosal injury • management of refractory symptoms at the end of life and the use of palliative sedation • advanced care planning in palliative care • bone health in cancer patients • cancer, fertility and pregnancy • management of chemotherapy extravasation • cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy • management of cancer pain • management of venous thromboembolism in cancer patients esmo-mcbs the esmo-magnitude of clinical benefit scale – promoting clear and unbiased communication about the benefit of cancer treatments pocket guidelines & mobile app download the new version of our app with the latest pocket guidelines for professionals and guides for patients esmo guidelines methodology to assist those using and/or evaluating the esmo guidelines, download the methodology here conferences esmo 2018 congress emuc 2018 – urological cancers esmo asia 2018 congress esmo immuno-oncology congress... esmo summit africa 2019 advanced ovarian cancer 2019 tat 2019 – international congr... ichno 2019 – head & neck cancer esmo summit latin america 2019 elcc 2019 - european lung canc... esmo breast cancer 2019 esmo 2019 congress esmo 2020 congress advanced courses preceptorship courses workshops & courses oncology conferences calendar esmo events app past conferences map 2018 – molecular analysis... esmo 2018 congress save the date for esmo 2018 congress. 19-23 october 2018, munich, germany emuc 2018 – urological cancers 10th european multidisciplinary congress on urological cancers - emuc 2018: 8-11 november 2018, amsterdam, the netherlands esmo asia 2018 congress join us in singapore for esmo asia 2018. 23-25 november 2018 esmo immuno-oncology congress 2018 join us in geneva, switzerland, 13-16 december 2018 esmo summit africa 2019 the esmo summit africa 2019 will take place in cape town, south africa: 15-17 february 2019 advanced ovarian cancer 2019 this symposium takes place 22 february 2019 in valencia, spain tat 2019 – international congress on targeted anticancer therapies tat 2019 will take place in paris, france. 25-27 february 2019 ichno 2019 – head & neck cancer ichno 2017 will be held in barcelona, spain. 14-16 march 2019 esmo summit latin america 2019 taking place 22-24 march 2019. registration will open on 1 october 2018. elcc 2019 - european lung cancer congress join us in geneva, switzerland, 10-13 april 2019 esmo breast cancer 2019 save the date for esmo breast cancer 2 – 4 may 2019, berlin, germany esmo 2019 congress save the date for esmo 2019. 27 september – 1 october 2019, barcelona, spain esmo 2020 congress esmo 2020 congress will take place from 18 to 22 september 2020. advanced courses the esmo advanced courses aim to address specific therapeutic challenges in patient management in different tumour settings. preceptorship courses apply now to join one of our preceptorship courses! workshops & courses esmo fos

URL analysis for esmo.org

https://www.esmo.org/ezsaml/login
https://www.esmo.org/research/research-groups-databases-and-tools
https://www.esmo.org/research
/www.esmo.org/rss/feed/esmo-news
https://www.esmo.org/patients/advocacy-in-action
https://www.esmo.org/career-development/women-for-oncology
https://www.esmo.org/guidelines/lung-and-chest-tumours
https://www.esmo.org/guidelines/neuro-oncology
https://www.esmo.org/about-us/how-we-work/general-assembly?hit=ehp
https://www.esmo.org/career-development/global-curriculum-in-medical-oncology
https://www.esmo.org/patients/patient-advocacy-track
https://www.esmo.org/about-us/connect-with-esmo
https://www.esmo.org/research/about-the-grant-schemes
https://www.esmo.org/guidelines/gastrointestinal-cancers
https://www.esmo.org/patients/designated-centres-working-group

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: ESMO.ORG
Registry Domain ID: D1407678-LROR
Registrar WHOIS Server:
Registrar URL: http://www.networksolutions.com
Updated Date: 2016-01-22T16:50:19Z
Creation Date: 1997-03-24T05:00:00Z
Registry Expiry Date: 2021-03-25T05:00:00Z
Registrar Registration Expiration Date:
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Reseller:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registry Registrant ID: C2987212-LROR
Registrant Name: European Society for Medical Oncology
Registrant Organization: European Society for Medical Oncology
Registrant Street: via L. Taddei 4
Registrant City: Viganello-Lugano
Registrant State/Province:
Registrant Postal Code: 6962
Registrant Country: CH
Registrant Phone: +41.919731900
Registrant Phone Ext:
Registrant Fax: +41.919731902
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID: C106124851-LROR
Admin Name: Andrea Norsa
Admin Organization: ESMO
Admin Street: European Society for Medical Oncology
Admin Street: Via L. Taddei 4
Admin City: Viganello-Lugano
Admin State/Province:
Admin Postal Code: 6962
Admin Country: CH
Admin Phone: +41.919731900
Admin Phone Ext:
Admin Fax: +41.919731902
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID: C106124851-LROR
Tech Name: Andrea Norsa
Tech Organization: ESMO
Tech Street: European Society for Medical Oncology
Tech Street: Via L. Taddei 4
Tech City: Viganello-Lugano
Tech State/Province:
Tech Postal Code: 6962
Tech Country: CH
Tech Phone: +41.919731900
Tech Phone Ext:
Tech Fax: +41.919731902
Tech Fax Ext:
Tech Email: [email protected]
Name Server: NS1.VIRTUALTEC.CH
Name Server: NS2.VIRTUALTEC.CH
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2017-07-13T11:38:09Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to: (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.

  REFERRER http://www.pir.org/

  REGISTRAR Public Interest Registry

SERVERS

  SERVER org.whois-servers.net

  ARGS esmo.org

  PORT 43

  TYPE domain

DOMAIN

  NAME esmo.org

  HANDLE D1407678-LROR

  CREATED 1997-03-24

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS1.VIRTUALTEC.CH 93.189.64.6

  NS2.VIRTUALTEC.CH 93.189.66.16

OWNER

  HANDLE C2987212-LROR

  NAME European Society for Medical Oncology

  ORGANIZATION European Society for Medical Oncology

ADDRESS

STREET
via L. Taddei 4

  CITY Viganello-Lugano

  PCODE 6962

  COUNTRY CH

  PHONE +41.919731900

  EMAIL [email protected]

ADMIN

  HANDLE C106124851-LROR

  NAME Andrea Norsa

  ORGANIZATION ESMO

ADDRESS

STREET
European Society for Medical Oncology
Via L. Taddei 4

  CITY Viganello-Lugano

  PCODE 6962

  COUNTRY CH

  PHONE +41.919731900

  EMAIL [email protected]

TECH

  HANDLE C106124851-LROR

  NAME Andrea Norsa

  ORGANIZATION ESMO

ADDRESS

STREET
European Society for Medical Oncology
Via L. Taddei 4

  CITY Viganello-Lugano

  PCODE 6962

  COUNTRY CH

  PHONE +41.919731900

  EMAIL [email protected]

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .